Vasodilators in heart failure.
نویسندگان
چکیده
منابع مشابه
Vasodilators in congestive heart failure.
1. Sarnoff SJ, Berglund E: Neurohemodynamics of pulmonary edema. IV. Effect of systemic vasoconstriction and subsequent vasodilation on flow and pressures in systemic and pulmonary vascular beds. Am J Physiol 170: 588, 1952 2. Imperial ES, Levy MN, Zieske H Jr: Outflow resistance as an independent determinant of cardiac performance. Circ Res 9: 1148, 1961 3. Sonnenblick EH, Downing SE: Afterloa...
متن کاملVasodilators Across the Heart Failure Spectrum
The term heart failure with preserved ejection fraction (HFpEF) has evolved to describe the broad clinical syndrome characterized by signs and symptoms of heart failure in patients in whom the ejection fraction (EF) falls within the low normal to normal range. This terminology is essentially descriptive, and implies neither etiology nor pathophysiology, although both continue to fuel vigorous d...
متن کاملVasodilators in Acute Heart Failure: Review of the Latest Studies.
Vasodilators play an important role in the management of acute heart failure, particularly when increased afterload is the precipitating cause of decompensation. The time-honored approach to afterload reduction has been largely focused on use of intravenous nitrovasodilators and, when properly dosed, this class of agents does provide substantial symptom relief for patients with acute hypertensi...
متن کاملRenal effects of vasodilators in acute heart failure
Vasodilator therapy is common in acute heart failure (AHF) patients, although evidence for morbidity and mortality benefits is limited for many of these drugs. AHF is frequently accompanied by renal dysfunction, which is a strong, independent predictor for poor prognosis. Several hemodynamic and neurohormonal effects of vasodilators—including preload and afterload reduction, activation or inhib...
متن کاملAdvances in Heart Failure The Effects of Vasodilators in Pulmonary Hypertension Pulmonary Vascular or Peripheral Vascular?
When primary pulmonary hypertension (PPH) was first described in the medical literature, it was characterized from a cardiac catheterization on a young woman who had an elevated pulmonary arterial pressure of unknown origin which, after the intravenous administration of acetylcholine, promptly fell.1 The sentinel description of this phenomenon led to the acceptance of PPH as a medical entity in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1982
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.284.6331.1788